No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy
This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
Aclaris Therapeutics Analyst Ratings
H.C. Wainwright Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating, Announces Target Price $20
Express News | Aclaris Therapeutics Inc : H.c. Wainwright Raises to Buy From Neutral
Express News | Aclaris Therapeutics Inc -Files Prospectus for Offer, Resale by Selling Stockholders of up to 35.6 Mln Shares of Common Stock